Literature DB >> 15386426

Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice.

Laurent Gate1, Rajrupa S Majumdar, Alexandra Lunk, Kenneth D Tew.   

Abstract

The role of glutathione S-transferase pi (GSTpi) in tumor development has been previously suggested; however the exact function of this enzyme in carcinogenesis remains unclear. GSTpi has been identified as a modulator of cell signaling by interacting with and inhibiting c-Jun N-terminal kinase (JNK). This kinase has been in turn described as a regulator of p53 stability and transcriptional activity. To study the possible interaction between GSTpi and p53, we crossed GSTpi-deficient animals with p53(-/-) mice. Double knock out animals were viable but developed tumors within 6 months of age; the life span of these animals was however similar to that of GSTpi(+/-)/p53(-/-) and GSTpi(+/+)/p53(-/-). Mice heterozygous for p53 lived significantly longer than the p53(-/-) animals and developed tumors much later, and the expression of GSTpi did not significantly modify the life span of the animals. In contrast, in a wild-type p53 background, GSTpi(-/-) mice developed tumors with a significantly higher frequency than heterozygous and wild-type animals with a median tumor free life span 20 weeks shorter. In addition, in p53(+/+) background, one third of the GSTpi(-/-) animals developed lung adenomas, while less than 10% of GSTpi(+/-) and GSTpi(+/+) presented such tumors. GSTpi expression did not alter the expression of tumorigenesis markers such as COX-2 or ornithine decarboxylase in response to phorbol ester. Furthermore, GSTpi-deficient mouse embryo fibroblasts were more sensitive to H(2)O(2)-induced apoptosis. P53(-/-) cells, independent of GSTpi status, were more sensitive to UV and other DNA damaging agents than their wild-type counterparts. These results suggest that GSTpi may play a protective role in the development of spontaneous tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15386426     DOI: 10.1002/ijc.20540

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Smoking-Related Gene Expression in Laser Capture-Microdissected Human Lung.

Authors:  Xiang-Lin Tan; Tao Wang; Shengli Xiong; Shalini V Kumar; Weiguo Han; Simon D Spivack
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

2.  Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity.

Authors:  Joachim D Uys; Lori Knackstedt; Phelipe Hurt; Kenneth D Tew; Yefim Manevich; Steven Hutchens; Danyelle M Townsend; Peter W Kalivas
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

3.  Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer.

Authors:  Pengfei Yu; Yian Du; Litao Yang; Sunfu Fan; Jian Wu; Shusen Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity.

Authors:  Danyelle M Townsend; Kenneth D Tew; Lin He; Jarrod B King; Marie H Hanigan
Journal:  Biomed Pharmacother       Date:  2008-09-07       Impact factor: 6.529

5.  Pleiotropic functions of glutathione S-transferase P.

Authors:  Jie Zhang; Christina Grek; Zhi-Wei Ye; Yefim Manevich; Kenneth D Tew; Danyelle M Townsend
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

6.  GST P1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death.

Authors:  Jie Chen; Anthony Liou; Lili Zhang; Zhongfang Weng; Yanqin Gao; Guodong Cao; Michael J Zigmond; Jun Chen
Journal:  Front Biosci (Elite Ed)       Date:  2012-06-01

7.  The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.

Authors:  Ming Geng; Lin Wang; Xin Chen; Ruixue Cao; Peifeng Li
Journal:  Diagn Pathol       Date:  2013-12-10       Impact factor: 2.644

8.  Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer.

Authors:  Pengfei Yu; Yian Du; Xiangdong Cheng; Qiming Yu; Ling Huang; Ruizeng Dong
Journal:  World J Surg Oncol       Date:  2014-10-11       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.